Evidence map›Paper›PMID 42182438›Full record

ArticlebioRxiv : the preprint server for biology2026

Engineered gut symbionts mediate cross-phylum antagonism to suppress uropathogenic

Jay Fuerte-Stone, Joyce Ghali, Sandra Valaitis, Mark Mimee

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jay Fuerte-StoneCommittee on Microbiology, University of Chicago, Chicago, IL 60637, USA.
Joyce GhaliCommittee on Molecular Metabolism and Nutrition, University of Chicago, Chicago, IL 60637, USA.
Sandra ValaitisUrogynocology, University of Chicago Medicine, Chicago, IL 60637, USA.
Mark MimeeCommittee on Microbiology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-3083-2671

Funding

Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Research Training in Digestive Health, Diseases, and NutritionT32DK007074 · NIDDK · UNIVERSITY OF CHICAGO · PI EUGENE B CHANG · 1986 to 2026
$11.3M
University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Microbial Engineering to Control the Structure and Function of the Gut Microbiome.R35GM147478 · NIGMS · UNIVERSITY OF CHICAGO · PI Mark Mimee · 2022 to 2026
$2.0M
NIDDK NIH HHS T32 DK007074NIGMS NIH HHS R25 GM109439NIGMS NIH HHS R35 GM147478NIGMS NIH HHS T32 GM007183
6 · The paper itself

Abstract

Urinary tract infections (UTIs) are among the most common bacterial infections globally and create a large burden on the healthcare system. Uropathogenic

Indexed as

bacterial antagonismMajor: Biological SciencesMicrobiomeMinor: Microbiologysynthetic biologyuropathogenic Escherichia coli

Identifiers

PMID42182438
PMCPMC13192842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.